Cidara Therapeutics' shares surge 218% this year after its flu candidate CD388 hits key mid-stage study goals and advances into pivotal testing.

MONTREAL, QC / ACCESS Newswire / September 26, 2025 / Vision Marine Technologies Inc. ("Vision Marine" or the "Company") (NASDAQ:VMAR) a company specializing in premium marine experiences and innovative propulsion solutions, today announced the renewal of the Executive Employment Agreement with Alexandre Mongeon as Chief Executive Officer of the Company, effective immediately. Mr. Mongeon co-founded Vision Marine Technologies and has been the driving force behind its evolution into North America's first vertically integrated electric propulsion and multi-brand retail marine platform.

With the S&P 500 surging as high as 6,700 before taking a bit of a breather to end the month, many investors have their sights set on the 7,000 milestone by year's end.

NEW YORK , Sept. 26, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Fastly, Inc. (NYSE: FSLY) breached their fiduciary duties to shareholders.

AEM, TFPM and NVT made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on September 26, 2025.

One year ago: Georgia Power mobilized its largest restoration operation ever to respond to the most destructive storm in the company's history; 2025 Atlantic Hurricane Season continues with storms developing that could impact Coastal Georgia ATLANTA , Sept. 26, 2025 /PRNewswire/ -- One year ago today, Hurricane Helene made landfall in Florida as a Category 4 hurricane before entering Georgia as a Category 2 storm, barreling through the state leaving behind unprecedented devastation.

A transformative infrastructure milestone decades in the making strengthens Maryland's economy and East Coast freight movement A transformative infrastructure milestone decades in the making strengthens Maryland's economy and East Coast freight movement

Nvidia (NASDAQ: NVDA) shares slipped over 1% at market open on Friday, September 26, despite Barclays upgrading NVDA's share price target from $200 to $240 just a day earlier.

Erin Pryor is recognized for leading client-centric growth and innovation. MEMPHIS, Tenn.

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Novo (NVO) To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Novo between May 7, 2025, to July 28, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648.

Inventiva (IVA) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

Viridian Therapeutics (VRDN) offers a differentiated next-gen therapy for Thyroid Eye Disease, targeting a large, underpenetrated market dominated by Amgen's Tepezza. VRDN-001 (veligrotug) demonstrates strong efficacy, shorter infusion times, and a superior safety profile, especially regarding hearing-related adverse events, versus Tepezza. Pipeline includes a promising subcutaneous (SC) version, VRDN-003, with potential for self-administration and a 1-2 year lead over competitors; robust cash reserves support development.

Daktronics (DAKT) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Lineage (LINE) To Contact Him Directly To Discuss Their Options If you purchased or acquired initial public offerings in Lineage and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648.

Investors love a story, and Oklo (NYSE: OKLO) has one of the punchiest on Wall Street. The California-based start-up, valued at $18bn, is pitching a future of pocket-sized nuclear power stations — called small modular reactors — that could light up data centres and factories from the late 2020s onwards.

Paychex is rated a hold due to limited near-term growth potential despite recent innovation and a strong cash position. The acquisition of Paycor expands PAYX's tech capabilities and client base, but has significantly increased the company's debt load. PAYX maintains industry-leading profitability and a solid dividend yield, yet faces headwinds from reduced ERTC benefits and integration risks.

Shares of Oklo Inc. NYSE: OKLO have delivered a strong performance in 2025, with a year-to-date gain of over 550% propelling its market capitalization to exceed $20 billion. This explosive growth has made it one of the most visible and actively traded stocks in the energy sector, commanding high trading volumes and capturing the attention of investors.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Shares of Wayfair Inc (NYSE:W) and RH (NYSE:RH) are reacting to President Donald Trump's tariff updates and inflation data that was in line with estimates.